documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
88 rows where agency_id = "FDA", document_type = "Rule" and posted_year = 2011 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, comment_end_date, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2011-D-0028-0003 | FDA | FDA-2011-D-0028 | Medical Devices: Ovarian Adnexal Mass Assessment Score Test System; Labeling; Black Box Restrictions | Rule | Final Rule | 2011-12-30T05:00:00Z | 2011 | 12 | 2011-12-30T05:00:00Z | 2011-12-30T14:31:25Z | 2011-33588 | 0 | 0 | 0900006480f8b788 | |
| FDA-2011-N-0003-0056 | FDA | FDA-2011-N-0003 | Ophthalmic and Topical Dosage Form New Animal Drugs: Ivermectin Topical Solution | Rule | Final Rule | 2011-12-29T05:00:00Z | 2011 | 12 | 2011-12-29T05:00:00Z | 2011-12-29T13:58:17Z | 2011-33382 | 0 | 0 | 0900006480f8acdf | |
| FDA-2007-N-0265-0007 | FDA | FDA-2007-N-0265 | Temperature-Indicating Devices: Thermally Processed Low-Acid Foods Packaged in Hermetically Sealed Containers; Correction | Rule | Correction | 2011-12-28T05:00:00Z | 2011 | 12 | 2011-12-28T05:00:00Z | 2011-12-28T20:10:32Z | 2011-33183 | 0 | 0 | 0900006480f8a284 | |
| FDA-2011-N-0003-0054 | FDA | FDA-2011-N-0003 | New Animal Drugs for Use in Animal Feeds: Monensin | Rule | Final Rule | 2011-12-21T05:00:00Z | 2011 | 12 | 2011-12-21T05:00:00Z | 2011-12-21T22:06:14Z | 2011-32427 | 0 | 0 | 0900006480f87099 | |
| FDA-2011-N-0003-0055 | FDA | FDA-2011-N-0003 | New Animal Drugs: Change of Sponsor; Zinc Gluconate | Rule | Final Rule | 2011-12-21T05:00:00Z | 2011 | 12 | 2011-12-21T05:00:00Z | 2011-12-21T22:32:43Z | 2011-32591 | 0 | 0 | 0900006480f87170 | |
| FDA-2011-N-0003-0052 | FDA | FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Cyclosporine | Rule | Final Rule | 2011-12-20T05:00:00Z | 2011 | 12 | 2011-12-20T05:00:00Z | 2011-12-20T15:34:59Z | 2011-32526 | 0 | 0 | 0900006480f864a7 | |
| FDA-2011-N-0898-0001 | FDA | FDA-2011-N-0898 | Applications for Food and Drug Administration Approval to Market New Drug: Revision of Postmarketing Reporting Requirements; Discontinuance | Rule | Notice of Interim Rule | 2011-12-19T05:00:00Z | 2011 | 12 | 2011-12-19T05:00:00Z | 2012-02-18T04:59:59Z | 2011-12-19T16:11:43Z | 2011-32354 | 0 | 0 | 0900006480f85979 |
| FDA-2011-N-0003-0048 | FDA | FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Estriol | Rule | Final Rule | 2011-12-16T05:00:00Z | 2011 | 12 | 2011-12-16T05:00:00Z | 2011-12-16T18:28:06Z | 2011-32214 | 0 | 0 | 0900006480f84681 | |
| FDA-2011-N-0003-0050 | FDA | FDA-2011-N-0003 | Ophthalmic and Topical Dosage Form New Animal Drugs: Hydrocortisone Aceponate, Miconazole Nitrate, and Gentamicin Sulfate Otic Suspension | Rule | Final Rule | 2011-12-16T05:00:00Z | 2011 | 12 | 2011-12-16T05:00:00Z | 2011-12-16T19:26:27Z | 2011-32226 | 0 | 0 | 0900006480f846b9 | |
| FDA-2011-N-0003-0044 | FDA | FDA-2011-N-0003 | New Animal Drugs for Use in AnimalFeeds: Tilmicosin | Rule | Final Rule | 2011-12-09T05:00:00Z | 2011 | 12 | 2011-12-09T16:06:45Z | 2011-31613 | 0 | 0 | 0900006480f7edc7 | ||
| FDA-2011-N-0003-0040 | FDA | FDA-2011-N-0003 | Ophthalmic and Topical Dosage Form New Animal Drugs; Eprinomectin | Rule | Final Rule | 2011-11-25T05:00:00Z | 2011 | 11 | 2011-11-25T05:00:00Z | 2011-11-25T14:20:46Z | 2011-30328 | 0 | 0 | 0900006480f73670 | |
| FDA-2011-N-0003-0039 | FDA | FDA-2011-N-0003 | Animal Drugs, Feeds, and Related Products; Eprinomectin; N-Methyl-2-Pyrrolidone | Rule | Final Rule | 2011-11-25T05:00:00Z | 2011 | 11 | 2011-11-25T14:23:01Z | 2011-30329 | 0 | 0 | 0900006480f73650 | ||
| FDA-2009-N-0025-0007 | FDA | FDA-2009-N-0025 | Animal Food Labeling; Declaration of Certifiable Color Additives | Rule | Final Rule | 2011-11-17T05:00:00Z | 2011 | 11 | 2011-11-17T05:00:00Z | 2015-03-25T11:53:37Z | 2011-29701 | 0 | 0 | 0900006480f6e620 | |
| FDA-2011-N-0003-0037 | FDA | FDA-2011-N-0003 | New Animal Drugs for Use in Animal Feeds: Melengestrol; Monensin; Tylosin | Rule | Final Rule | 2011-10-20T04:00:00Z | 2011 | 10 | 2011-10-20T04:00:00Z | 2011-10-20T14:02:09Z | 2011-27139 | 0 | 0 | 0900006480f56b31 | |
| FDA-1993-N-0259-0024 | FDA | Quality Standard for Foods With No Identity Standards; Bottled Water FDA-1993-N-0259 | Beverages; Bottled Water Quality Standard: Establishing an Allowable Level for di(2-ethylhexyl)phthalate - Notice of Final Rule Effective 4/16/2012 | Rule | Final Rule | 2011-10-19T04:00:00Z | 2011 | 10 | 2011-10-19T04:00:00Z | 2012-01-31T15:11:52Z | 2011-26707 | 0 | 0 | 0900006480f55cfd | |
| FDA-2011-N-0003-0035 | FDA | FDA-2011-N-0003 | New Animal Drugs for Use in Animal Feeds: Melengestrol; Monensin | Rule | Final Rule | 2011-09-30T04:00:00Z | 2011 | 9 | 2011-09-30T04:00:00Z | 2011-09-30T13:05:07Z | 2011-25220 | 0 | 0 | 0900006480f45b6a | |
| FDA-2009-C-0543-0005 | FDA | FDA-2009-C-0543 | Listing of Color Additives Exempt from Certification: Reactive Blue 69; Confirmation of Effective Date | Rule | Final Rule | 2011-09-27T04:00:00Z | 2011 | 9 | 2011-09-27T04:00:00Z | 2012-03-24T19:33:33Z | 2011-24795 | 0 | 0 | 0900006480f35047 | |
| FDA-2011-N-0011-0001 | FDA | FDA-2011-N-0011 | Environmental Impact Considerations, Food Additives, and Generally Recognized as Safe Substances: Technical Amendments | Rule | Final Rule | 2011-09-26T04:00:00Z | 2011 | 9 | 2011-09-26T04:00:00Z | 2011-09-26T14:45:43Z | 2011-24455 | 0 | 0 | 0900006480f2be2f | |
| FDA-2011-N-0003-0033 | FDA | FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Tylosin | Rule | Final Rule | 2011-09-23T04:00:00Z | 2011 | 9 | 2011-09-23T04:00:00Z | 2011-09-23T13:49:15Z | 2011-24461 | 0 | 0 | 0900006480f28536 | |
| FDA-2011-N-0003-0031 | FDA | FDA-2011-N-0003 | New Animal Drugs: Gamithromycin | Rule | Final Rule | 2011-09-19T04:00:00Z | 2011 | 9 | 2011-09-19T04:00:00Z | 2011-09-19T16:38:18Z | 2011-23874 | 0 | 0 | 0900006480f22065 | |
| FDA-2011-N-0003-0030 | FDA | FDA-2011-N-0003 | Tolerances for Residues of New Animal Drugs in Food: Progesterone | Rule | Final Rule | 2011-09-19T04:00:00Z | 2011 | 9 | 2011-09-19T04:00:00Z | 2011-09-19T16:31:42Z | 2011-23867 | 0 | 0 | 0900006480f220a7 | |
| FDA-2011-N-0003-0028 | FDA | FDA-2011-N-0003 | Implantation or Injectable Dosage Form New Animal Drugs: Ivermectin | Rule | Final Rule | 2011-09-19T04:00:00Z | 2011 | 9 | 2011-09-19T04:00:00Z | 2011-09-19T16:03:53Z | 2011-23865 | 0 | 0 | 0900006480f22114 | |
| FDA-2011-N-0002-0099 | FDA | FDA-2011-N-0002 | Advisory Committee; Change of Name and Function: Technical Amendment | Rule | Final Rule | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2011-08-30T14:34:08Z | 2011-22105 | 0 | 0 | 0900006480f08cf5 | |
| FDA-2011-N-0003-0027 | FDA | FDA-2011-N-0003 | New Animal Drugs: Ampicillin Trihydrate, Bacitracin Methylene Disalicylate, Flunixin, etc.; Correcting Amendments | Rule | Correction | 2011-08-25T04:00:00Z | 2011 | 8 | 2011-08-25T13:40:34Z | 2011-21721 | 0 | 0 | 0900006480eee4b8 | ||
| FDA-2004-N-0061-0056 | FDA | Human Subject Protection; Foreign Clinical Studies Not Conducted Under an Investigational New Drug Application FDA-2004-N-0061 | See FDA-2004-N-0061-0002 | Rule | Final Rule | 2011-08-22T04:00:00Z | 2011 | 8 | 2011-08-22T04:00:00Z | 2011-08-22T17:51:39Z | 0 | 0 | 0900006480ee8af2 | ||
| FDA-2011-M-0570-0001 | FDA | FDA-2011-M-0570 | Medical Devices: Ophthalmic Devices; Classification of the Eyelid Thermal Pulsation System | Rule | Final Rule | 2011-08-19T04:00:00Z | 2011 | 8 | 2011-08-19T18:02:44Z | 2011-21195 | 0 | 0 | 0900006480ee5693 | ||
| FDA-2010-N-0412-0004 | FDA | FDA-2010-N-0412 | Effective Date of Requirement for Premarket Approval for Three Class III Preamendments Devices | Rule | Final Rule | 2011-08-16T04:00:00Z | 2011 | 8 | 2011-08-16T04:00:00Z | 2012-03-24T19:34:54Z | 2011-20664 | 0 | 0 | 0900006480ee2241 | |
| FDA-2011-N-0003-0026 | FDA | FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Change of Sponsor; Chlortetracycline; Sulfamethazine | Rule | Final Rule | 2011-08-11T04:00:00Z | 2011 | 8 | 2011-08-11T13:46:29Z | 2011-20404 | 0 | 0 | 0900006480edde3b | ||
| FDA-2010-N-0429-0002 | FDA | FDA-2010-N-0429 | Immunology and Microbiology Devices: Reclassification of the Herpes Simplex Virus Serological Assay Device | Rule | Final Rule | 2011-08-09T04:00:00Z | 2011 | 8 | 2011-08-09T04:00:00Z | 2012-03-24T19:30:33Z | 2011-20115 | 0 | 0 | 0900006480edbab0 | |
| FDA-2011-N-0003-0025 | FDA | FDA-2011-N-0003 | New Animal Drugs: Change of Sponsor; Moxidectin | Rule | Final Rule | 2011-08-09T04:00:00Z | 2011 | 8 | 2011-08-09T04:00:00Z | 2011-08-09T14:46:08Z | 2011-20182 | 0 | 0 | 0900006480edbacf | |
| FDA-2011-N-0002-0083 | FDA | FDA-2011-N-0002 | Medical Imaging Drugs Advisory Committee; Re-establishment | Rule | Final Rule | 2011-07-29T04:00:00Z | 2011 | 7 | 2011-07-29T13:13:02Z | 2011-19064 | 0 | 0 | 0900006480ecf3fc | ||
| FDA-1995-N-0031-0005 | FDA | OTC Bronchodilator Drug Products FDA-1995-N-0031 | Labeling for Bronchodilators to Treat Asthma; Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products, etc. | Rule | Final Rule | 2011-07-26T04:00:00Z | 2011 | 7 | 2011-07-26T04:00:00Z | 2011-07-28T14:06:22Z | 2011-18347 | 0 | 0 | 0900006480ecb779 | |
| FDA-2011-N-0466-0001 | FDA | FDA-2011-N-0466 | Medical Devices; Neurological Devices: Classification of Repetitive Transcranial Magnetic Stimulation System | Rule | Final Rule | 2011-07-26T04:00:00Z | 2011 | 7 | 2011-07-26T04:00:00Z | 2011-07-26T16:20:14Z | 2011-18806 | 0 | 0 | 0900006480ecb764 | |
| FDA-2007-N-0092-0002 | FDA | FDA-2007-N-0092 | Cardiovascular Devices: Classification of Electrocardiograph Electrodes | Rule | Final Rule | 2011-07-21T04:00:00Z | 2011 | 7 | 2011-07-21T04:00:00Z | 2011-07-21T13:23:56Z | 2011-18391 | 0 | 0 | 0900006480ec80ef | |
| FDA-2011-N-0499-0001 | FDA | FDA-2011-N-0499 | Medical Devices; General and Plastic Surgery Devices: Classification of the Focused Ultrasound Stimulator System for Aesthetic Use | Rule | Final Rule | 2011-07-20T04:00:00Z | 2011 | 7 | 2011-07-20T04:00:00Z | 2011-07-20T14:47:30Z | 2011-18278 | 0 | 0 | 0900006480ec6fe2 | |
| FDA-2010-F-0103-0002 | FDA | FDA-2010-F-0103 | Food Additives Permitted for Human Consumption: Hydroxypropyl Cellulose | Rule | Final Rule | 2011-07-15T04:00:00Z | 2011 | 7 | 2011-07-15T04:00:00Z | 2011-08-16T03:59:59Z | 2011-07-18T20:20:35Z | 2011-17928 | 0 | 0 | 0900006480ec321d |
| FDA-2011-N-0003-0023 | FDA | FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Amprolium | Rule | Final Rule | 2011-07-12T04:00:00Z | 2011 | 7 | 2011-07-12T04:00:00Z | 2011-07-12T14:34:01Z | 2011-17465 | 0 | 0 | 0900006480ec062c | |
| FDA-2011-N-0003-0022 | FDA | FDA-2011-N-0003 | New Animal Drugs: Change of Sponsor's Name and Address | Rule | Final Rule | 2011-07-11T04:00:00Z | 2011 | 7 | 2011-07-11T04:00:00Z | 2011-07-11T13:50:45Z | 2011-17292 | 0 | 0 | 0900006480ebef6a | |
| FDA-2011-N-0003-0021 | FDA | FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs; Change of Sponsor | Rule | Final Rule | 2011-07-08T04:00:00Z | 2011 | 7 | 2011-07-08T04:00:00Z | 2011-07-08T19:06:59Z | 2011-17151 | 0 | 0 | 0900006480ebcfab | |
| FDA-2011-N-0033-0004 | FDA | FDA-2011-N-0033 | Oral Dosage Form New Animal Drugs; Change of Sponsor | Rule | 2011-07-08T00:00:00Z | 2011 | 7 | 2011-07-08T16:56:38Z | 0 | 1 | 0900006480ebcd27 | ||||
| FDA-2011-N-0003-0020 | FDA | FDA-2011-N-0003 | New Animal Drugs: Change of Sponsor's Address | Rule | Final Rule | 2011-07-06T04:00:00Z | 2011 | 7 | 2011-07-06T04:00:00Z | 2011-07-06T18:50:24Z | 2011-16845 | 0 | 0 | 0900006480eba135 | |
| FDA-2010-N-0646-0018 | FDA | FDA-2010-N-0646 | Tobacco Products: Exemptions From Substantial Equivalence Requirements | Rule | Final Rule | 2011-07-05T04:00:00Z | 2011 | 7 | 2011-07-05T04:00:00Z | 2012-03-24T19:31:41Z | 2011-16766 | 0 | 0 | 0900006480eb965f | |
| FDA-2011-N-0003-0019 | FDA | FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Amprolium | Rule | Final Rule | 2011-07-01T04:00:00Z | 2011 | 7 | 2011-07-01T04:00:00Z | 2011-07-01T14:40:14Z | 2011-16501 | 0 | 0 | 0900006480eb82fd | |
| FDA-2003-N-0212-0005 | FDA | Medical Devices; Exception from General Requirements for Informed Consent FDA-2003-N-0212 | Notice of Final Rule re Medical Devices: Exception From General Requirements for Informed Consent | Rule | Final Rule | 2011-06-24T04:00:00Z | 2011 | 6 | 2011-06-24T04:00:00Z | 2015-12-07T16:16:06Z | 2011-15816 | 0 | 0 | 0900006480eb3487 | |
| FDA-1997-N-0040-0086 | FDA | Current Good Tissue Practice for Mfrs. of Human Cellular FDA-1997-N-0040 | Final Rule re Medical Devices: Neurological Devices; Clarification of Classification for Human Dura Mater; Technical Amendment | Rule | Final Rule | 2011-06-24T04:00:00Z | 2011 | 6 | 2011-06-24T04:00:00Z | 2016-02-02T16:10:30Z | 2011-15817 | 0 | 0 | 0900006480eb3482 | |
| FDA-2010-N-0568-0251 | FDA | FDA-2010-N-0568 | Required Warnings for Cigarette Packages and Advertisements; Final Rule | Rule | Final Rule | 2011-06-22T04:00:00Z | 2011 | 6 | 2011-06-22T04:00:00Z | 2011-06-22T15:40:34Z | 2011-15337 | 0 | 0 | 0900006480e8b8e4 | |
| FDA-1978-N-0018-0698 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Labeling and Effectiveness Testing: Sunscreen Drug Products for Over-the-Counter Human Use | Rule | Final Rule | 2011-06-17T04:00:00Z | 2011 | 6 | 2011-06-17T04:00:00Z | 2017-12-07T17:18:11Z | 2011-14766 | 0 | 0 | 0900006480e52002 | |
| FDA-2011-N-0361-0001 | FDA | FDA-2011-N-0361 | Medical Devices: Ear, Nose, and Throat Devices; Classification of the Wireless Air-Conduction Hearing Aid | Rule | Final Rule | 2011-06-15T04:00:00Z | 2011 | 6 | 2011-06-15T04:00:00Z | 2011-06-16T12:31:30Z | 2011-14790 | 0 | 0 | 0900006480e50807 | |
| FDA-2006-D-0094-0005 | FDA | Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Topical Oxygen Chamber for Extremities FDA-2006-D-0094 | Guidance for Industry and Food and Drug Administration Staff; Availability: Class II Special Controls; Topical Oxygen Chamber for Extremities; Availability; Correction | Rule | NCR-Notice of Correction | 2011-05-20T04:00:00Z | 2011 | 5 | 2011-05-20T04:00:00Z | 2011-05-20T13:29:50Z | 2011-12409 | 0 | 0 | 0900006480db8764 | |
| FDA-2006-N-0045-0003 | FDA | General and Plastic Surgery Devices; Reclassification of the Topical Oxygen Chamber for Extremities FDA-2006-N-0045 | Medical Devices; Reclassification of the Topical Oxygen Chamber for Extremities; Correction | Rule | NCR-Notice of Correction | 2011-05-20T04:00:00Z | 2011 | 5 | 2011-05-20T04:00:00Z | 2011-05-20T13:09:00Z | 2011-12410 | 0 | 0 | 0900006480db88b0 | |
| FDA-2011-N-0003-0017 | FDA | FDA-2011-N-0003 | Implantation or Injectable Dosage Form New Animal Drugs: Gonadotropin Releasing Factor-Diphtheria Toxoid Conjugate | Rule | NFR-Notice of Final Rule | 2011-05-13T04:00:00Z | 2011 | 5 | 2011-05-13T04:00:00Z | 2011-05-13T12:55:58Z | 2011-11762 | 0 | 0 | 0900006480c79e08 | |
| FDA-2011-N-0179-0001 | FDA | FDA-2011-N-0179 | Information Required in Prior Notice of Imported Food | Rule | NIR-Notice of Interim Rule | 2011-05-05T04:00:00Z | 2011 | 5 | 2011-05-05T04:00:00Z | 2011-08-04T03:59:59Z | 2011-06-11T16:30:42Z | 2011-10955 | 0 | 0 | 0900006480c3fc6b |
| FDA-2011-N-0197-0001 | FDA | FDA-2011-N-0197 | Criteria Used to Order Administrative Detention of Food for Human or Animal Consumption | Rule | NIR-Notice of Interim Rule | 2011-05-05T04:00:00Z | 2011 | 5 | 2011-05-05T04:00:00Z | 2011-08-04T03:59:59Z | 2011-06-11T16:30:42Z | 2011-10953 | 0 | 0 | 0900006480c3fcd7 |
| FDA-2009-C-0543-0002 | FDA | FDA-2009-C-0543 | Listing of Color Additives Exempt From Certification; Reactive Blue 69 | Rule | NFR-Notice of Final Rule | 2011-05-04T04:00:00Z | 2011 | 5 | 2011-05-04T04:00:00Z | 2011-06-04T03:59:59Z | 2011-05-04T16:40:21Z | 2011-10869 | 0 | 0 | 0900006480c3eb0f |
| FDA-2006-N-0045-0002 | FDA | General and Plastic Surgery Devices; Reclassification of the Topical Oxygen Chamber for Extremities FDA-2006-N-0045 | Medical Devices: Reclassification of the Topical Oxygen Chamber for Extremities | Rule | NFR-Notice of Final Rule | 2011-04-25T04:00:00Z | 2011 | 4 | 2011-04-25T04:00:00Z | 2011-04-25T19:09:56Z | 2011-09899 | 0 | 0 | 0900006480c372bf | |
| FDA-2011-N-0003-0015 | FDA | FDA-2011-N-0003 | Implantation or Injectable Dosage Form New Animal Drugs: Enrofloxacin | Rule | NFR-Notice of Final Rule | 2011-04-22T04:00:00Z | 2011 | 4 | 2011-04-22T04:00:00Z | 2011-04-22T13:02:12Z | 2011-09765 | 0 | 0 | 0900006480c35d41 | |
| FDA-2011-N-0118-0001 | FDA | FDA-2011-N-0118 | Medical Devices; Obstetrical and Gynecological Devices: Classification of the Hemorrhoid Prevention Pressure Wedge | Rule | NFR-Notice of Final Rule | 2011-04-15T04:00:00Z | 2011 | 4 | 2011-04-15T04:00:00Z | 2011-04-15T13:49:53Z | 2011-09141 | 0 | 0 | 0900006480c2dedd | |
| FDA-2011-N-0188-0001 | FDA | FDA-2011-N-0188 | Medical Devices; General and Plastic Surgery Devices: Classification of the Low Level Laser System for Aesthetic Use | Rule | NFR-Notice of Final Rule | 2011-04-14T04:00:00Z | 2011 | 4 | 2011-04-14T04:00:00Z | 2011-04-14T16:36:11Z | 2011-08944 | 0 | 0 | 0900006480c2c67b | |
| FDA-2010-N-0099-0009 | FDA | FDA-2010-N-0099 | Revision of the Requirements for Constituent Materials | Rule | NFR-Notice of Final Rule | 2011-04-13T04:00:00Z | 2011 | 4 | 2011-04-13T17:06:13Z | 2011-08885 | 0 | 0 | 0900006480c25e58 | ||
| FDA-1998-F-0072-0004 | FDA | safe use of ionizing radition for reduction of salmonella. CLOSED FDA-1998-F-0072 | Irradiation in the Production, Processing, and Handling of Food | Rule | NFR-Notice of Final Rule | 2011-04-13T04:00:00Z | 2011 | 4 | 2011-04-14T15:23:49Z | 2011-08815 | 0 | 0 | 0900006480c25ec1 | ||
| FDA-2011-N-0003-0011 | FDA | FDA-2011-N-0003 | Oral Dosages Form New Animal Drugs: Robenacoxib | Rule | NFR-Notice of Final Rule | 2011-04-05T04:00:00Z | 2011 | 4 | 2011-04-05T04:00:00Z | 2011-04-05T13:54:22Z | 2011-08053 | 0 | 0 | 0900006480c1bc56 | |
| FDA-2011-N-0160-0001 | FDA | FDA-2011-N-0160 | Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications; Chorionic Gonadotropin; Cuprimyxin; Diethylcarbamazine; Levamisole; Nitrofurazone; Phenylbutazone; Pyrantel; Tylosin; Tylosin and Sulfamethazine | Rule | NFR-Notice of Final Rule | 2011-03-31T04:00:00Z | 2011 | 3 | 2011-03-31T04:00:00Z | 2011-04-20T16:01:00Z | 2011-07560 | 0 | 0 | 0900006480c15845 | |
| FDA-2011-N-0003-0009 | FDA | FDA-2011-N-0003 | New Animal Drugs: Amikacin Sulfate, Ampicillin Trihydrate, Ceftiofur Hydrochloride, Cephapirin Benzathine, etc.; Correcting Amendments | Rule | NCR-Notice of Correction | 2011-03-29T04:00:00Z | 2011 | 3 | 2011-03-29T04:00:00Z | 2011-03-29T13:29:20Z | 2011-07313 | 0 | 0 | 0900006480c1279e | |
| FDA-2011-N-0003-0007 | FDA | FDA-2011-N-0003 | New Animal Drugs: Oxytetracycline | Rule | NFR-Notice of Final Rule | 2011-03-28T04:00:00Z | 2011 | 3 | 2011-03-28T04:00:00Z | 2011-03-28T14:44:26Z | 2011-07216 | 0 | 0 | 0900006480c11e79 | |
| FDA-2011-N-0003-0008 | FDA | FDA-2011-N-0003 | New Animal Drugs: Arsanilate Sodium; Sulfaethoxypyridazine | Rule | NFR-Notice of Final Rule | 2011-03-28T04:00:00Z | 2011 | 3 | 2011-03-28T04:00:00Z | 2011-03-28T14:56:22Z | 2011-07214 | 0 | 0 | 0900006480c11e7a | |
| FDA-2011-N-0003-0006 | FDA | FDA-2011-N-0003 | Tolerances for Residues of New Animal Drugs in Food: 2-Acetylamino-5-Nitrothiazole; Buquinolate; Chlorobutanol; Estradiol and Related Esters, etc.; Correcting Amendments | Rule | NFR-Notice of Final Rule | 2011-03-25T04:00:00Z | 2011 | 3 | 2011-03-25T04:00:00Z | 2011-03-25T15:07:49Z | 2011-06796 | 0 | 0 | 0900006480c10d09 | |
| FDA-2010-N-0002-0095 | FDA | FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor's Name and Address; Corrections | Rule | NCR-Notice of Correction | 2011-03-24T04:00:00Z | 2011 | 3 | 2011-03-24T04:00:00Z | 2011-03-24T13:39:40Z | 2011-6795 | 0 | 0 | 0900006480c0f8fd | |
| FDA-2010-N-0002-0097 | FDA | FDA-2010-N-0002 | Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications; Aklomide; Levamisole Hydrochloride; Nitromide and Sulfanitran; Roxarsone; Correction | Rule | NCR-Notice of Correction | 2011-03-24T04:00:00Z | 2011 | 3 | 2011-03-24T04:00:00Z | 2011-03-24T13:46:28Z | 2011-6790 | 0 | 0 | 0900006480c0fd1e | |
| FDA-2010-N-0002-0096 | FDA | FDA-2010-N-0002 | New Animal Drugs for Use in Animal Feeds: Florfenicol; Correction | Rule | NCR-Notice of Correction | 2011-03-24T04:00:00Z | 2011 | 3 | 2011-03-24T04:00:00Z | 2011-03-24T13:42:25Z | 2011-6789 | 0 | 0 | 0900006480c0fd16 | |
| FDA-2010-N-0002-0098 | FDA | FDA-2010-N-0002 | Certain Other Dosage Form New Animal Drugs: Detomidine; Correction | Rule | NCR-Notice of Correction | 2011-03-24T04:00:00Z | 2011 | 3 | 2011-03-24T04:00:00Z | 2011-03-24T13:48:54Z | 2011-06791 | 0 | 0 | 0900006480c0fd2a | |
| FDA-2011-N-0026-0001 | FDA | FDA-2011-N-0026 | Medical Devices; Immunology and Microbiology Devices: Classification of Ovarian Adnexal Mass Assessment Score Test System | Rule | NFR-Notice of Final Rule | 2011-03-23T04:00:00Z | 2011 | 3 | 2011-03-23T19:40:15Z | 2011-06620 | 0 | 0 | 0900006480c0ec97 | ||
| FDA-2002-F-0198-0007 | FDA | Safe Use of Mix of Bacteriophages/Antimicrobial Agent FDA-2002-F-0198 | Food Additives Permitted for Direct Addition to Food for Human Consumption: Bacteriophage Preparation | Rule | NFR-Notice of Final Rule | 2011-03-23T04:00:00Z | 2011 | 3 | 2011-03-23T04:00:00Z | 2011-03-23T16:07:13Z | 2011-06792 | 0 | 0 | 0900006480c0ed08 | |
| FDA-1999-F-0056-0004 | FDA | National Fisheries Institute and the Louisiana Department of Agriculture FDA-1999-F-0056 | Irradiation in the Production, Processing, and Handling of Food | Rule | NCD-Notice of Confirmation of Effective Date | 2011-03-22T04:00:00Z | 2011 | 3 | 2011-03-22T04:00:00Z | 2011-03-22T14:06:19Z | 2011-06625 | 0 | 0 | 0900006480c0d376 | |
| FDA-2011-N-0130-0001 | FDA | FDA-2011-N-0130 | Investigational New Drug Applications and Abbreviated New Drug Applications | Rule | NFR-Notice of Final Rule | 2011-03-15T04:00:00Z | 2011 | 3 | 2011-03-15T04:00:00Z | 2011-03-15T18:33:35Z | 2011-05946 | 0 | 0 | 0900006480c07efc | |
| FDA-2011-N-0101-0001 | FDA | FDA-2011-N-0101 | Requests for Exemption From the Bar Code Label Requirements; Change of Address | Rule | NFR-Notice of Final Rule | 2011-03-09T05:00:00Z | 2011 | 3 | 2011-03-09T05:00:00Z | 2011-03-09T19:06:33Z | 2011-05288 | 0 | 0 | 0900006480c04017 | |
| FDA-2011-N-0003-0004 | FDA | FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Spinosad and Milbemycin Oxime | Rule | NFR-Notice of Final Rule | 2011-03-08T05:00:00Z | 2011 | 3 | 2011-03-08T05:00:00Z | 2011-03-08T16:02:16Z | 2011-05144 | 0 | 0 | 0900006480c0323d | |
| FDA-2010-N-0560-0004 | FDA | FDA-2010-N-0560 | Amendments to General Regulations of the Food and Drug Administration | Rule | NFR-Notice of Final Rule | 2011-03-08T05:00:00Z | 2011 | 3 | 2011-03-08T05:00:00Z | 2011-06-11T16:28:38Z | 2011-05147 | 0 | 0 | 0900006480c032bb | |
| FDA-2007-N-0265-0005 | FDA | FDA-2007-N-0265 | Temperature-Indicating Devices: Thermally Processed Low-Acid Foods Packaged in Hermetically Sealed Containers | Rule | NFR-Notice of Final Rule | 2011-03-03T05:00:00Z | 2011 | 3 | 2011-03-03T05:00:00Z | 2011-03-03T14:17:30Z | 2011-04475 | 0 | 0 | 0900006480bfe0cb | |
| FDA-2010-N-0534-0003 | FDA | FDA-2010-N-0534 | New Animal Drugs for Minor Use and Minor Species; Confirmation of Effective Date | Rule | NCD-Notice of Confirmation of Effective Date | 2011-03-02T05:00:00Z | 2011 | 3 | 2011-03-02T05:00:00Z | 2011-06-11T16:28:38Z | 2011-04593 | 0 | 0 | 0900006480bfcc1c | |
| FDA-2010-F-0200-0002 | FDA | FDA-2010-F-0200 | Secondary Direct Food Additives Permitted in Food for Human Consumption | Rule | NFR-Notice of Final Rule | 2011-03-02T05:00:00Z | 2011 | 3 | 2011-03-02T05:00:00Z | 2011-04-02T03:59:59Z | 2011-03-02T16:42:43Z | 2011-04497 | 0 | 0 | 0900006480bfcbd5 |
| FDA-2008-N-0106-0032 | FDA | FDA-2008-N-0106 | Medical Devices; Medical Device Data Systems | Rule | NFR-Notice of Final Rule | 2011-02-15T05:00:00Z | 2011 | 2 | 2011-02-15T05:00:00Z | 2011-04-11T16:53:32Z | 2011-03321 | 0 | 0 | 0900006480bef5e2 | |
| FDA-2009-F-0525-0005 | FDA | FDA-2009-F-0525 | Food Additives Permitted in Feed and Drinking Water of Animals: Formic Acid | Rule | NFR-Notice of Final Rule | 2011-02-09T05:00:00Z | 2011 | 2 | 2011-02-09T05:00:00Z | 2011-03-12T04:59:59Z | 2011-02-09T14:41:31Z | 2011-02789 | 0 | 0 | 0900006480beaac9 |
| FDA-2010-D-0645-0002 | FDA | FDA-2010-D-0645 | Medical Devices: General and Plastic Surgery Devices; Classification of Contact Cooling System for Aesthetic Use | Rule | NFR-Notice of Final Rule | 2011-02-07T05:00:00Z | 2011 | 2 | 2011-02-07T05:00:00Z | 2011-02-07T15:41:57Z | 2011-02552 | 0 | 0 | 0900006480bdd15e | |
| FDA-2011-N-0003-0001 | FDA | FDA-2011-N-0003 | New Animal Drugs: Masitinib | Rule | NFR-Notice of Final Rule | 2011-02-04T05:00:00Z | 2011 | 2 | 2011-02-04T05:00:00Z | 2011-02-04T15:32:40Z | 2011-2519 | 0 | 0 | 0900006480bdbad8 | |
| FDA-2010-N-0002-0092 | FDA | FDA-2010-N-0002 | Implantation or Injectable Dosage Form New Animal Drugs: Oxytetracycline and Flunixin | Rule | NFR-Notice of Final Rule | 2011-01-20T05:00:00Z | 2011 | 1 | 2011-01-20T05:00:00Z | 2011-01-20T14:05:26Z | 2011-01040 | 0 | 0 | 0900006480bce9e7 | |
| FDA-2010-N-0002-0091 | FDA | FDA-2010-N-0002 | New Animal Drugs: Change of Sponsor | Rule | NFR-Notice of Final Rule | 2011-01-18T05:00:00Z | 2011 | 1 | 2011-01-18T05:00:00Z | 2011-01-18T14:54:02Z | 2011-904 | 0 | 0 | 0900006480bcce2d | |
| FDA-2010-N-0002-0090 | FDA | FDA-2010-N-0002 | New Animal Drugs: Follicle Stimulating Hormone; Change of Sponsor | Rule | NFR-Notice of Final Rule | 2011-01-18T05:00:00Z | 2011 | 1 | 2011-01-18T05:00:00Z | 2011-01-18T14:51:10Z | 2011-909 | 0 | 0 | 0900006480bccd28 | |
| FDA-2009-N-0592-0069 | FDA | FDA-2009-N-0592 | Informed Consent Elements | Rule | NFR-Notice of Final Rule | 2011-01-04T05:00:00Z | 2011 | 1 | 2011-01-04T05:00:00Z | 2011-06-11T16:28:13Z | 2010-33193 | 0 | 0 | 0900006480bc4ae4 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);